Working with its clients to ensure a successful outcome in terms of market access, Grove local consultants provide expert advice in three key areas:
While membership of the EU has meant a move to regulatory harmonization, the Latvian healthcare sector remains underfunded and pricing and reimbursement systems are complex.
Recognizing the challenges of encouraging manufacturers to invest in a small market such as the Latvian market, regulators are keen to reform the current regulatory system. Although inevitably it will take some time, it is hoped that dialogue between manufacturers and the regulators will ultimately result in a more streamlined, investor-friendly regulatory system.
The Latvian State Agency of Medicines (SAM) plays the key role in the market for medicines, medical devices, food supplements and cosmetics.
The still complex regulatory procedures in the Latvian market require careful navigation. Only with an understanding of local reimbursement policies, can new market entrants hope to get their own reimbursement strategies and subsequent reimbursement submissions right. With experienced local consultants based, Grove can assist with: